Categories Uncategorized

United Medical Equipment Business Solutions Network Inc. Providing Solutions to Combat the Spread of COVID-19

  • UME is trusted supplier of FDA-approved antibody, antigen test kits
  • United moved quickly to address growing needs created by COVID-19
  • Company dedicated to providing guidance to aging population, their families and medical staff supporting them

United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted supplier of FDA-approved antibody and antigen test kits, medical equipment and personal protective equipment (“PPE”). As the world attempts to control this pandemic, it is essential to quickly identify who is infected and who has already been infected. Antibody testing determines whether or not a patient has had COVID-19 in the past while antigen testing determines whether or not a patient currently has COVID-19.

An antibody test can help determine how many people have had and recovered from COVID-19. This includes those that were asymptomatic. Since individuals are presenting various symptoms, ranging from no symptoms to full respiratory failure, symptoms alone cannot accurately confirm if someone has been infected. Antibody tests have limited use in detection but help to determine accurate case numbers and research into immunity.

The antigen rapid test allows for quick diagnosis that can help curb the spread of the virus. Antigens are a specific protein that sits on the surface of the virus. These rapid tests identify antigens when the individual is contagious. That individual can then be placed into quarantine, stopping the spread of the virus (https://ibn.fm/xB6J7).

The FDA-approved CareStart(TM) COVID-19 Antigen Rapid POC test is part of United’s answer in combating the spread of the virus. The test is administered by medical professionals to detect COVID-19 antigens. This test identifies acute infection with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike (https://ibn.fm/9pjpf).

United moved quickly to address the growing needs created by the COVID-19 pandemic. In addition to providing test kits, COVID-19 supplies and products (https://ibn.fm/KgD8i), and PPE equipment with flexible payment options, the company has acted as a trusted senior referral source for independent living, assisted living, hospice, memory care, skilled nursing and senior care centers.

Throughout 2020 and into 2021, the elderly have been particularly vulnerable to this pandemic. United is dedicated to providing guidance for the aging population, their families, and the medical community that serves them.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

New Photodynamic Therapy Offers Hope Against Brain Cancer

A planned preclinical study testing a light-activated therapy that helps to kill residual brain cancer cells after…

23 hours ago

Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies

Researchers have developed a technological platform that leverages yeast cells to test and understand new cancer treatments…

2 days ago

The Anti-Dilution Playbook: How Earth Science Tech Inc. (ETST) Rewrote the OTC Capital Structure Narrative

The company has issued zero common shares since October 2023, marking a decisive break from…

2 days ago

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

LIXTE’s lead compound, LB-100, targets PP2A, a central regulator of cancer cell survival and treatment…

3 days ago

Policy Expert Offers Suggestions for Curbing US Health Care Costs

According to recent data, health expenditures in the U.S. reached $5.3 trillion in 2024. That figure equates…

4 days ago

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

Although CTCL may progress slowly in its early stages, it remains a chronic and ultimately…

5 days ago